These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23906997)

  • 1. HIV and HCV among people who inject drugs in Central Asia.
    Walsh N; Maher L
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S37-40. PubMed ID: 23906997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
    Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
    J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan.
    Latypov A; Otiashvili D; Zule W
    Int J Drug Policy; 2014 Nov; 25(6):1204-14. PubMed ID: 25449057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
    Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
    Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
    Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L
    Lancet Glob Health; 2017 Dec; 5(12):e1208-e1220. PubMed ID: 29074410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
    Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
    Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
    Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature.
    Grenfell P; Baptista Leite R; Garfein R; de Lussigny S; Platt L; Rhodes T
    Drug Alcohol Depend; 2013 May; 129(3):180-209. PubMed ID: 23306095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination.
    Leyna GH; Makyao N; Mwijage A; Ramadhan A; Likindikoki S; Mizinduko M; Leshabari MT; Moen K; Mmbaga EJ
    Harm Reduct J; 2019 Dec; 16(1):68. PubMed ID: 31829199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.
    Patel EU; Solomon SS; Mcfall AM; Srikrishnan AK; Pradeep A; Nandagopal P; Laeyendecker O; Tobian AAR; Thomas DL; Sulkowski MS; Kumar MS; Mehta SH
    Int J Drug Policy; 2018 Jul; 57():51-60. PubMed ID: 29679811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. People who inject drugs in Bangladesh - The untold burden!
    Khan SI; Reza MM; Crowe SM; Rahman M; Hellard M; Sarker MS; Chowdhury EI; Rana AKMM; Sacks-Davis R; Banu S; Ross AG
    Int J Infect Dis; 2019 Jun; 83():109-115. PubMed ID: 30928433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis.
    Akbarzadeh V; Mumtaz GR; Awad SF; Weiss HA; Abu-Raddad LJ
    BMC Public Health; 2016 Dec; 16(1):1216. PubMed ID: 27912737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan.
    Ruiseñor-Escudero H; Wirtz AL; Berry M; Mfochive-Njindan I; Paikan F; Yousufi HA; Yadav RS; Burnham G; Vu A
    Drug Alcohol Depend; 2014 Oct; 143():127-33. PubMed ID: 25131717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.